N

Novartis Venture Fund portfolio

Novartis Venture Fund has 3 portfolio companies on record at Recent Funding. Its most recent investment on record is Splice Bio's $140M Series B+ round in June 2025, alongside Ysios Capital, UCB Ventures, Sanofi Ventures and 5 others. By category, its portfolio leans toward Health and bio (3) and Legal and compliance (1). It has co-invested with Forbion Capital Partners, Gilde Healthcare and Vesalius Biocapital Partners, most often Forbion Capital Partners (4 rounds).

What Novartis Venture Fund invests in

• Health and bio · 3 · 100%
• Legal and compliance · 1 · 33%

Novartis Venture Fund recent investments

Company	Round	Date	Alongside
SSplice Bio	Series B+ · $140M	Jun 11, 2025	Ysios Capital, UCB Ventures, Sanofi Ventures (lead) +5
CCatalYm	Series B+ · $150M	Jul 16, 2024	Vesalius Biocapital Partners, Omega Funds, Jeito Capital +5
CCatalYm	Series B+ · $50M	Nov 22, 2022	Vesalius Biocapital Partners, Jeito Capital (lead), Forbion Capital Partners +4
SSplice Bio	Series A · $57M	Feb 1, 2022	Ysios Capital (lead), UCB Ventures (lead), NEA +2
AAnaveon	Series B+ · $120M	Dec 16, 2021	Syncona Partners LLP, Pontifax, Pfizer Venture Investments +2
CCatalYm	Series B+ · $59.04M	Nov 10, 2020	Wachstumsfonds Bayern, Vesalius Biocapital Partners (lead), Forbion Capital Partners +2
AAnaveon	Series A · $35M	Feb 1, 2019	Syncona Partners LLP (lead)

How Novartis Venture Fund invests

Share is of the 7 rounds on Recent Funding that name Novartis Venture Fund. Rounds with no announced date are left out of the year split, and "round" is a round whose stage is not on file.

Novartis Venture Fund portfolio companies

• SSplice Bio$140MSeries B+ · Jun 2025
• CCatalYm$150MSeries B+ · Jul 2024
• AAnaveon$120MSeries B+ · Dec 2021

Company	Round with Novartis Venture Fund	Total raised	Latest raise
SSplice Bio Health and bio	Jun 11, 2025 Series B+ · $140M	$197M	Jun 11, 2025 Series B+
CCatalYm Health and bio	Jul 16, 2024 Series B+ · $150M	$259.04M	Jul 16, 2024 Series B+
AAnaveon Legal and compliance	Dec 16, 2021 Series B+ · $120M	$155M	Dec 16, 2021 Series B+

Most frequent co-investors

• FForbion Capital Partners4 shared rounds · last Jul 16, 2024
• GGilde Healthcare3 shared rounds · last Jun 11, 2025
• VVesalius Biocapital Partners3 shared rounds · last Jul 16, 2024
• NNEA2 shared rounds · last Jun 11, 2025
• AAsabys Partners2 shared rounds · last Jun 11, 2025
• YYsios Capital2 shared rounds · last Jun 11, 2025
• UUCB Ventures2 shared rounds · last Jun 11, 2025
• BBrandon Capital2 shared rounds · last Jul 16, 2024
• JJeito Capital2 shared rounds · last Jul 16, 2024
• BBioGeneration Ventures2 shared rounds · last Nov 22, 2022
• Ccoparion2 shared rounds · last Nov 22, 2022
• SSyncona Partners LLP2 shared rounds · last Dec 16, 2021

Similar investors

• PPositive Sum3 companies · 4 deals in 12 mo
• IInnovestor3 companies · 3 deals in 12 mo
• FFrazier Life Sciences3 companies · 2 deals in 12 mo
• GGoHub Ventures3 companies · 2 deals in 12 mo
• HHealthier Capital3 companies · 2 deals in 12 mo
• KKadmos Capital3 companies · 2 deals in 12 mo

Investors whose portfolios on Recent Funding center on the same category (Health and bio).

Portfolio companies are the companies on Recent Funding with a round that lists Novartis Venture Fund, which is a subset of its real portfolio. API: /api/v1/investors/novartis-venture-fund (get a free API key). More: the most active VC firms and new venture capital funds.